We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Viatris
VTRS
$20.4B
| $877K | 0.01% |
91,153
+64,467
| +242% | +$715K |
|
|
CBAY
877
DELISTED
Cymabay Therapeutics
CBAY
| $875K | 0.01% |
+100,342
| New | +$803K |
|
878
Micron Technology
MU
$930B
| $873K | 0.01% |
14,468
+7,266
| +101% | +$426K |
|
879
CME Group
CME
$96.3B
| $873K | 0.01% |
4,558
-4,210
| -48% | -$761K |
|
880
KB Home
KBH
$3.37B
| $872K | 0.01% |
21,705
+12,661
| +140% | +$462K |
|
|
DFS
881
DELISTED
Discover Financial Services
DFS
| $872K | 0.01% |
8,818
+1,566
| +22% | +$168K |
|
882
J.M. Smucker
SJM
$12.7B
| $870K | 0.01% |
5,531
+1,554
| +39% | +$236K |
|
883
Cleveland-Cliffs
CLF
$6.57B
| $867K | 0.01% |
47,322
+32,489
| +219% | +$643K |
|
884
Aflac
AFL
$64.9B
| $865K | 0.01% |
13,412
+3,789
| +39% | +$259K |
|
885
Fox Class A
FOXA
$24.5B
| $863K | 0.01% |
+25,337
| New | +$856K |
|
886
Plug Power
PLUG
$2.87B
| $862K | 0.01% |
73,566
+52,143
| +243% | +$746K |
|
887
Nutrien
NTR
$33.2B
| $862K | 0.01% |
11,669
+133
| +1% | +$10.3K |
|
888
Mondelez International
MDLZ
$79.5B
| $861K | 0.01% |
12,351
-13,602
| -52% | -$901K |
|
889
Fortune Brands Innovations
FBIN
$5.88B
| $857K | 0.01% |
14,596
-7,316
| -33% | -$447K |
|
890
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $856K | 0.01% |
+16,938
| New | +$850K |
|
891
ResMed
RMD
$30.6B
| $856K | 0.01% |
3,909
+931
| +31% | +$202K |
|
892
AutoZone
AZO
$49.2B
| $853K | 0.01% |
347
+105
| +43% | +$256K |
|
893
STAG Industrial
STAG
$7.38B
| $853K | 0.01% |
25,221
-19,561
| -44% | -$667K |
|
894
Voya Financial
VOYA
$9.01B
| $850K | 0.01% |
+11,896
| New | +$833K |
|
895
Invesco Senior Loan ETF
BKLN
$6.97B
| $847K | 0.01% |
+40,702
| New | +$852K |
|
|
ANSS
896
DELISTED
Ansys
ANSS
| $844K | 0.01% |
2,537
-9,107
| -78% | -$2.57M |
|
897
Essex Property Trust
ESS
$18.3B
| $844K | 0.01% |
4,035
-814
| -17% | -$180K |
|
898
Skyworks Solutions
SWKS
$9.37B
| $843K | 0.01% |
7,144
+4,912
| +220% | +$544K |
|
899
Paycom
PAYC
$7.64B
| $841K | 0.01% |
2,766
+2,043
| +283% | +$615K |
|
900
Burlington
BURL
$23.2B
| $840K | 0.01% |
4,156
+3,064
| +281% | +$669K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.